Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piotr Ciura

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The Journal of Physical Chemistry. B|July 3, 2024
Multilayered Computational Framework for Designing Peptide Inhibitors of HVEM-LIGHT InteractionPiotr Ciura, Pamela Smardz, Marta Spodzieja, et al.
Bioorganic Chemistry|November 6, 2025
HVEM-derived peptides as inhibitors of HVEM/LIGHT complex formationPiotr Ciura, Simon Gumpelmair, Emilia Sikorska, et al.
Journal of Medicinal Chemistry|November 30, 2025
CD160-Derived Peptide as a Bidirectional Inhibitor Toward Immune Checkpoints BTLA/HVEM and HVEM/LIGHTMagdalena Lipińska, Piotr Ciura, Simon Gumpelmair, et al.
Translational Oncology|February 15, 2024
Peptide-based inhibitors targeting the PD-1/PD-L1 axis: potential immunotherapeutics for cancerMagdalena Bojko, Katarzyna Węgrzyn, Emilia Sikorska, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Journal of Physical Chemistry. B|July 3, 2024
Multilayered Computational Framework for Designing Peptide Inhibitors of HVEM-LIGHT InteractionPiotr Ciura, Pamela Smardz, Marta Spodzieja, et al.
Bioorganic Chemistry|November 6, 2025
HVEM-derived peptides as inhibitors of HVEM/LIGHT complex formationPiotr Ciura, Simon Gumpelmair, Emilia Sikorska, et al.
Journal of Medicinal Chemistry|November 30, 2025
CD160-Derived Peptide as a Bidirectional Inhibitor Toward Immune Checkpoints BTLA/HVEM and HVEM/LIGHTMagdalena Lipińska, Piotr Ciura, Simon Gumpelmair, et al.
Translational Oncology|February 15, 2024
Peptide-based inhibitors targeting the PD-1/PD-L1 axis: potential immunotherapeutics for cancerMagdalena Bojko, Katarzyna Węgrzyn, Emilia Sikorska, et al.
Pageof 1